Contact Us

Drug Discovery

Target Dossier Services

Target identification is an essential first step toward the discovery and development of any new therapeutic. Consequently, successful pharma organizations perform due diligence around a target of interest before embarking on the long, time-consuming, expensive and high-risk endeavor of drug development. It is therefore essential to establish a link between the target and the disease with an overlap between mechanism of action of the drug and disease pathophysiology. Ultimately, clinical translatability to ensure that a drug’s activity against the target is efficacious with minimal side effects, marks the crucial difference between success and failure of drug development.

Excelra’ s Custom Target Dossier Services

Excelra is strongly positioned to deliver tailor-made target assessment dossiers based on unique requirements of our global Biotech and Pharma clients. The dossier is a compendium of information on the complete target profile including structural, systemic and functional aspects of a protein and the gene-encoding it.

To facilitate critical ‘Go/No-go decision making’, we provide a 360-degree view of a target detailing:

  1. Role in healthy tissues as well as its association with disease(s).
  2. Molecular pharmacology, target expression across human tissues/organs, species, gene alterations and target interactions with other proteins/genes.
  3. Competitive landscape of drug development by stage (approved, clinical & pre-clinical drugs).
  4. Adverse events or toxicity data for compounds at any stage of development.
  5. ON- and OFF- target safety assessment and de-risking strategies.

With a host of additional features, Excelra’s custom target dossier reports provide actionable insights that apply to various use-case scenarios in drug discovery and development, as detailed below.